Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.0029 | 0.9 |
mRNA | AZD0530 | CCLE | pan-cancer | AAC | 0.0037 | 0.9 |
mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | 0.0025 | 0.9 |
mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | -0.0027 | 0.9 |
mRNA | L-685458 | CCLE | pan-cancer | AAC | 0.0033 | 0.9 |
mRNA | A-804598 | CTRPv2 | pan-cancer | AAC | -0.0029 | 0.9 |
mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | -0.0021 | 1 |
mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | -0.0033 | 1 |
mRNA | Platin | CTRPv2 | pan-cancer | AAC | 0.0023 | 1 |
mRNA | BMS-708163 | GDSC1000 | pan-cancer | AAC | 0.0021 | 1 |